Researchers at the University of British Columbia have identified a new form of hereditary prostate cancer that, while rare, ...

Akeega prostate cancer UK approval: the MHRA has licensed Johnson and Johnson's niraparib-abiraterone combination for men ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. This voice experience is generated by AI. Learn more. This voice ...

CANYON COUNTY — Prostate cancer is the second leading cause of cancer death in men, with about one in seven men being diagnosed with prostate cancer in their lifetime, according to the American Cancer ...

The National Comprehensive Cancer Network recommends germline genetic testing for patients with prostate cancer and high-risk features or a suggestive family history. In 2024, the University of ...

Researchers have uncovered a rare inherited mutation linked to prostate cancer—and it could help identify at-risk families ...

(Aging Untold) — Prostate cancer is one of the most common cancers for men in the United States, but deciding when to get screened isn’t always clear. While a PSA blood test can help find prostate ...

Men are being forced to go private for tests as they are not eligible under current guidelines ...

Focusing prostate cancer testing on men at highest risk of developing the disease is likely to improve the ratio between benefits and the harms of screening, suggests a paper published today in BMJ.